Evaluation of repeated micropulse cyclophotocoagulation in patients with refractory glaucoma

PURPOSE. To evaluate the efficacy and safety of repeated micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with previously operated refractory glaucoma. MATERIALS AND METHODS. We examined 89 aged 74.2±7.3 years moderate (16), advanced (58) terminal (15) stages uncompensated primary openangle glaucoma (POAG) before within 12 months after first MP-TSCPC (SUPRA 810, “Quantel Medical”, France) using standard laser parameters — 100 J. Indications for were determined 23 3 (1 patient), 6 (14 patients), 9 (8 patients) procedure. Repeated was carried out higher impact energy 125 RESULTS. After procedure, hypotensive effect achieved 66 (74.2%) lasting up to follow-up. reduced IOP by 31.2% moderate, 31.8% advanced, 22.9% (p<0.05) As a result, during observation, (single double) led stabilization 83.1% cases. CONCLUSION. Single TSCPC energies J is an effective safe method treating A single followed (laser J) 74 (83.1%) patients. It possible revise basic procedure from achieve longer at same time